Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal autologous mesenchymal stem cells for amyotrophic lateral sclerosis
IRCT20200828048551N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of autologous mesenchymal stem cells in amyotrophic lateral sclerosis (ALS), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2020; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on IRCT20200828048551N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200828048551N1.